Evidence map›Paper›PMID 36329079›Full record

ReviewNature reviews. Disease primers2022

Asplenia and spleen hypofunction.

Marco Vincenzo Lenti, Sarah Luu, Rita Carsetti, Faith Osier, Rodney Ogwang, Obiageli E Nnodu, Ursula Wiedermann, Jo Spencer, Franco Locatelli, Gino Roberto Corazza and 1 more

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Disease primers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Guideline
  2. Macrophage heterogeneity in human secondary lymphoid organs.Clinical science (London, England : 1979) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 7 countries.

Marco Vincenzo LentiDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.ORCID 0000-0002-6654-4911
Sarah LuuMonash Infectious Diseases, Monash Health, Clayton, Victoria, Australia.ORCID 0000-0001-9983-1709
Rita CarsettiB cell Unit, Immunology Research Area, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Faith OsierKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.ORCID 0000-0001-7133-5375
Rodney OgwangKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.
Obiageli E NnoduDepartment of Haematology and Blood Transfusion, College of Health Sciences, University of Abuja, Abuja, Nigeria.
Ursula WiedermannInstitute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Jo SpencerPeter Gorer Department of Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID 0000-0002-7202-2431
Franco LocatelliDepartment of Paediatric Haematology/Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Catholic University of the Sacred Heart, Rome, Italy.ORCID 0000-0002-7976-3654
Gino Roberto CorazzaDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
Antonio Di SabatinoDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy. a.disabatino@smatteo.pv.it.ORCID 0000-0002-0302-8645
University of Pavia · ITKenya Medical Research Institute · KEBambino Gesù Children's Hospital · ITKing's College London · GBMedical University of Vienna · ATMonash Health · AUUniversità Cattolica del Sacro Cuore · ITUniversity of Abuja · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asplenia (the congenital or acquired absence of the spleen) and hyposplenism (defective spleen function) are common causes of morbidity and mortality. The spleen is a secondary lymphoid organ that is responsible for the regulation of immune responses and blood filtration. Hence, asplenia or hyposplenism increases susceptibility to severe and invasive infections, especially those sustained by encapsulated bacteria (namely, Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b). Asplenia is predominantly due to splenectomy for either traumatic events or oncohaematological conditions. Hyposplenism can be caused by several conditions, including haematological, infectious, autoimmune and gastrointestinal disorders. Anatomical disruption of the spleen and depletion of immune cells, especially IgM memory B cells, seem to be predominantly responsible for the clinical manifestations. Early recognition of hyposplenism and proper management of asplenia are warranted to prevent overwhelming post-splenectomy infections through vaccination and antibiotic prophylaxis. Although recommendations are available, the implementation of vaccination strategies, including more effective and immunogenic vaccines, is needed. Additionally, screening programmes for early detection of hyposplenism in high-risk patients and improvement of patient education are warranted.

Indexed as

Bacterial InfectionsSplenic DiseasesAntibiotic ProphylaxisHumansSplenectomy

Identifiers

PMID36329079
OpenAlexW4308370377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.